CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer

Stopped Study was closed because investigator left the National Institutes of Health.

Conditions

• Thyroid Neoplasms
• Poorly Differentiated and Undifferentiated Thyroid Cancer
• Differentiated Thyroid Cancer

Interventions

• DRUG: CUDC-907

Sponsor

National Cancer Institute (NCI)